Company Performance Metrics
Kayash Pharma develops and markets pharmaceutical formulations across multiple therapeutic categories. The company focuses on gastroenterology, orthopedics, gynecology, and general therapeutics, offering oral solid doses, syrups, suspensions, softgel capsules, and injectables. Its portfolio includes branded products such as Kay-Q10 softgel
capsules, Kyaspan-DSR capsules, Mekopred injection, KYASCAL-D3 tablets, Kay-SP tablets, Livk-SF syrup, and KC-Raft suspension. Kayash Pharma aligns product development and distribution with established regulatory guidelines and quality standards. The company supplies its medicines through healthcare professionals and pharmaceutical distribution channels to address a range of common and chronic conditions within its therapeutic focus areas.